Patent Right Extensions Clause Samples

Patent Right Extensions. Subject to the remainder of this Section ‎12.6 (Patent Right Extensions), Sarepta will have the sole right to elect and file for patent term restoration or extension, supplemental protection certificate, or any of their equivalents (hereinafter, “Patent Term Extensions”) with respect to Sarepta Prosecuted Patent Rights or other Sarepta Arising Patent Rights for any Licensed Product in the Territory, provided that, for the avoidance of doubt, Sarepta may not file a request for a Patent Term Extension for any Arrowhead Platform Patent Rights without Arrowhead’s prior written consent, which consent shall not be unreasonably withheld, conditioned, or delayed. The Parties will discuss the strategy with respect to Patent Term Extensions and ▇▇▇▇▇▇▇ will consider ▇▇▇▇▇▇▇▇▇’s comments in good faith. Upon Sarepta’s request and at its cost and expense, Arrowhead will reasonably cooperate with Sarepta in any fillings made by Sarepta pursuant to this Section 12.6 (Patent Right Extensions). Sarepta will bear all Patent Costs incurred by Sarepta in making any such filing in the Territory for such Licensed Product.

Patent Right Extensions. 62 iii 12.5. Third Party Rights ...................................................................................... 62 12.6.

Patent Right Extensions. Neurocrine will have the right to elect and file for patent term restoration or extension, supplemental protection certificate, or any of their equivalents with respect to Neurocrine Prosecuted Patent Rights in the Territory. Neurocrine will inform Takeda of any such decision. Neurocrine will be responsible for applying for any patent term extension. Upon the request by Neurocrine, Takeda will reasonably cooperate in the implementation of Neurocrine’s decisions made pursuant to this Section 13.4 (Patent Right Extensions). During the period of a PSP P&L Share for a Profit-Share Product, the Parties will share the applicable Patent Costs incurred by Neurocrine in furtherance of such filing for such Profit-Share Product in accordance with Section 9.2.1 (Profit and Loss Share) and for any Royalty-Bearing Product, Neurocrine will bear all such Patent Costs.

Patent Right Extensions. Subject to the remainder of this Section 12.8 (Patent Right Extensions), Novartis will have the sole right to elect and file for patent term restoration or extension, supplemental protection certificate, or any of their equivalents (hereinafter, “Patent Term Extensions”) with respect to Novartis Prosecuted Patent Rights or other Novartis Arising Patent Rights for any Licensed Product in the Territory, provided that, for the avoidance of doubt, Novartis may not file a request for a Patent Term Extension for any Arrowhead Platform Patent Rights without Arrowhead’s prior written consent, which consent will not be unreasonably withheld, conditioned, or delayed. [***]. Upon Novartis’ request and at its cost and expense, Arrowhead will reasonably cooperate with Novartis in any fillings made by Novartis pursuant to this Section 12.8 (Patent Right Extensions). Novartis will bear all Patent Costs incurred by Novartis in making any such filing in the Territory for such Licensed Product. [***].

Patent Right Extensions. Takeda will have the full and exclusive right and discretion to determine and control all filings of requests for patent term extensions, supplementary protection certificates, or equivalents thereto in any country in the Territory, in each case, where applicable to a Licensed Product (hereinafter “Patent Term Extensions”) for Joint Arising Patent Rights and Arising Patent Rights. Takeda may not file a Patent Term Extension for a Licensed Patent Right without Innate’s prior written consent, not to be unreasonably withheld, conditioned, or delayed, except that Takeda will have the full and exclusive right to extend a Licensed Patent Right that is not an NKCE Patent Right if there are no granted Patent Rights that are Controlled by Takeda Covering the composition of matter or method of use in the approved labeling for the applicable Licensed Product as of the date of Regulatory Approval for such Licensed Product. All costs and expenses relating to the Patent Term Extensions will be borne solely by Takeda. Upon the reasonable request of Takeda and at Takeda’s cost and expense, Innate will provide support, assistance, and all necessary documents, in full executed form if needed, to Takeda for the purpose of supporting, filing, obtaining, and maintaining Patent Term Extensions. Notwithstanding the foregoing, Takeda may only extend a Method of Use Patent Right under this Section 8.6 (Patent Right Extensions) if Takeda’s right to Patent Term Extension arises from an Antibody Product.

Patent Right Extensions. 12.4.1. By Neurocrine. Neurocrine will have the right to elect and file for patent term restoration or extension, supplemental protection certificate, or any of their equivalents with respect to Neurocrine Prosecuted Patent Rights worldwide for Licensed Other Products and in the Neurocrine Territory for TAK-653 Products. Neurocrine will inform ▇▇▇▇▇▇ of any such decision. Neurocrine will be responsible for applying for any such patent term extension. Upon the request by ▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇ will reasonably cooperate in the implementation of Neurocrine’s decisions made pursuant to this Section 12.4 (Patent Right Extensions). Neurocrine will bear the applicable Patent Costs incurred by Neurocrine in furtherance of such filing for any Licensed Product in the Territory.

Patent Right Extensions. Takeda will have the sole right to elect and file for patent term restoration or extension, supplemental protection certificate, or any of their equivalents with respect to Takeda Prosecuted Patent Rights in the Territory. Takeda will inform Arrowhead of any such decision. Takeda will be responsible for applying for any patent term extension. Upon the request by Takeda, Arrowhead will reasonably cooperate in the implementation of Takeda’s decisions made pursuant to this Section 14.4 (Patent Right Extensions). The Parties will share the applicable Patent Costs incurred by Takeda in furtherance of such filing in the Profit-Share Territory for such Product in accordance with Section 10.2.1 (Profit and Loss Share), and for any Product in the Takeda Territory, Takeda will bear all such Patent Costs.